HALO logo
DNA
Ginkgo Bioworks Holdings, Inc. Class A

DNA · Ginkgo Bioworks Holdings, Inc. Class A

10.27

USD
-1.49 (-12.67%)
16/10/2026 04:10:00 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$719.99M

PE

N/A

EV/EBITDA

N/A

DIV Yield

N/A

Payout Ratio

N/A

MQV Rating

5Very Weak

As at 16/10/2026 04:10:00 PM

Price Chart

Description

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

  • All-Companies
  • All-Consensus
  • Big Candle
  • Big Candle (Realtime)
  • Consensus Expensive
  • HALO All
  • HALO Price Momentum
  • Hammer Bullish
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

N/A

Trade Value (12mth)

N/A

1 week

%

1 month

%

YTD

%

1 year

%

All time high

N/A

Additional Data

Shares Outstanding (Fully Diluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

N/A

Short Sell (% of issue)

lock

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
07 August 26EDG
07 August 26EDG
06 August 26EDG
06 August 26EDG
31 July 26EDG

Key Stakeholders

NameTitle
Cascade Investment LLCPrivate Company
SB Investment Advisers (UK) Ltd.Subsidiary
Reshma ShettyIndividual
Austin CheIndividual
Bartholomew CantonIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS)?
Halo FAQ
The current share price of Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) is USD$10.27.
2
What is the 52-week high share price for Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS)?
Halo FAQ
The 52-week high share price for Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) is USD$0.00.
3
What is the 52-week low share price for Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS)?
Halo FAQ
The 52-week low share price for Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) is USD$0.00.
4
What is the dividend yield for Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS)?
Halo FAQ
Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) does not pay a dividend.
5
What was Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) last dividend payment?
Halo FAQ
Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) does not pay a dividend.
6
What is the franking level for Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS)?
Halo FAQ
Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) has a franking level of 0.00%.
7
In which sector is Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) classified?
Halo FAQ
Ginkgo Bioworks Holdings, Inc. Class A (DNA:NYS) is classified in the Healthcare.